Intracoronary Imaging and Intracoronary Functional Tests
Feature Histology OCT IVUS In general Resolution 1 μm 10–20 μm 100–250 μm Imaging depth ∞ 1–2.5 mm 8–10 mm Detailed surface morphology + + – Vessel remodeling + –…
Feature Histology OCT IVUS In general Resolution 1 μm 10–20 μm 100–250 μm Imaging depth ∞ 1–2.5 mm 8–10 mm Detailed surface morphology + + – Vessel remodeling + –…
Fig. 7.1 (a) BAV performed with a 22 mm balloon catheter in a woman with a mean annuls diameter of 21 mm. (b) Annulus rupture through the free LV myocardial…
Fig. 4.1 Recommended indications for the invasive and conservative strategies for the treatment of NSTE-ACS according to risk stratification (MI myocardial infarction, CKD chronic kidney disease, LVEF left ventricular ejection…
Drug Comparison Type of study Indication No. of individuals Follow-up Efficacy endpoint Relative risk (95 % CI) Safety endpoint Relative risk (95 % CI) Reference Acetylsalicylic acid Acetylsali-cylic acid Placebo…
Coronary heart disease Acute coronary syndromes Hypertension Often associated with left ventricular hypertrophy and preserved ejection fraction Cardiomyopathies Familial/genetic or non-familial/non-genetic (including acquired, e.g. myocarditis) Hypertrophic (HCM), dilated (DCM), restrictive…
Fig. 28.1 Thoratec HeartMate II Left Ventricular Assist Device (LVAD). Left; LVAD system complete with external controller connected to the LVAD via a percutaneous drive line with power input from…
Fig. 19.1 This figure demonstrates the subtle differences in ischemic mitral regurgitation (IMR) and functional mitral regurgitation (FMR) (Reprinted from Timek and Miller [7], © 2011, with permission from Elsevier)…
Structural heart disease Reentry Triggered activity Automaticity Infarct-related cardiomyopathy Coronary artery disease/Myocardial infarction ++++ + ++ Non-ischemic cardiomyopathy Dilated cardiomyopathy ++++ + ++ Hypertrophic cardiomyopathy ++++ + + Arrhythmogenic RV…
Fig. 21.1 Steps in T lymphocyte activation and proliferation. Panel a Multiple signals are required for T cell activation and proliferation in response to alloantigen recognition. Panel b Donor antigens…
Fig. 30.1 Stem and progenitor cells defined by proliferative and differentiation capacity. This figure depicts the reduction in proliferative potential and differentiation potential during cell maturation. It should be kept…